Aquestive Therapeutics, Inc. (AQST) Social Stream



Aquestive Therapeutics, Inc. (AQST): $1.11

-0.04 (-3.48%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AQUESTIVE THERAPEUTICS INC (AQST) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AQUESTIVE THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $28 $7 $16.333 $1.14 1332.72%
2021-12-23 2 $26 $7 $15.666 $1.14 1274.21%
2022-03-10 2 $14 $7 $9.666 $1.14 747.89%
2022-05-04 2 $14 $8 $11 $1.14 864.91%
2022-06-16 2 $8 $8 $8 $1.14 601.75%
2022-07-11 2 $8 $5 $6.5 $1.14 470.18%
2022-08-04 2 $5 $4 $4.5 $1.14 294.74%
2022-08-15 2 $6 $4 $5 $1.14 338.6%
2022-08-30 2 $10 $4 $6.666 $1.14 484.74%
2022-09-06 3 $10 $4 $6.333 $1.14 455.53%
2022-09-28 3 $10 $4 $6.875 $1.14 503.07%

The Trend in the Analyst Price Target


Over the past 20 months, AQST's average price target has gone down $8.12.

Over the past 46 weeks, AQST's average upside potential has been 476.56%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-10 2 14 8 11.000 2.550 331.37%
2022-03-10 2 14 7 9.666 2.550 279.06%
2022-05-31 2 8 8 8.000 0.994 704.83%
2022-07-11 2 8 5 6.500 0.820 692.68%
2022-09-28 3 10 4 7.125 1.160 514.22%

AQST Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 39 weeks, AQST's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, AQUESTIVE THERAPEUTICS INC's number of analysts covering the stock is higher than 65.67% of them.
  • In terms of how AQUESTIVE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1120.14% of that group.
  • To contextualize these metrics, consider that out of all US stocks, AQUESTIVE THERAPEUTICS INC's average analyst price target is greater than 100.7% of them.
  • AQST has a lower variance in analysts' estimates than -703.02% of stocks in the small market cap category.

Stocks similar to AQUESTIVE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APTX, APRE, and APM.

Is AQST a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5235 seconds.